Avatrombopag tablets simulated drug

Avatrombopag is an oral drug that belongs to the thrombopoietin receptor agonist (TPO-R agonist) class of drugs. Its main action is to increase platelet count by stimulating platelet production in the bone marrow. Avatrombopag tablets are commonly used to treat idiopathic thrombocytopenic purpura (ITP), an immune disease in which the patient's immune system mistakenly attacks and destroys its own platelets, resulting in a low number of platelets and easy bleeding. Avatrombopag is already on the market in China and is covered by medical insurance. Domestic patients can easily purchase it. The price is about three to four thousand yuan, but the specific price and medical insurance reimbursement information need to be subject to the information of the local hospital pharmacy. In addition, for patients looking for a more economical option, relatively cheap generic versions of avatrombopag are available in foreign markets, especially Laos and Bangladesh, with prices ranging from a few hundred to a thousand yuan. These generic drugs are highly similar in composition to the original drugs.